reference/34463382

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34463382

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't\|Research Support, N.I.H., Extramural
endingPage	654
issn	1740-7745 1740-7753
issueIdentifier	6
pageRange	647-654
publicationName	Clinical trials (London, England)
startingPage	647
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_34b4e16e990f9a32c674a1a638728bcf http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_3da5d5672f7fa276ad729c4704fe280d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_199db1bef4b0308c0639203aa0befa4f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_06aba5a94448c92faf09747c7e7c67bd http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_7364eeb3d98cfbf3b0d0a3c13b9064a1
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_feab88a3fdf428ebac8f58048cf696f5 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8e7c3651e6e7802b6d6a08f60ff67a38 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_afb0240ba48605ff95a8fffd109be75e http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_669b6a06194fa519b32504e1f7061952 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_51e3abe25675fec59e5a4942af09a8ee http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_45d13e5bb992070083e111745d6dd09d
bibliographicCitation	Longini IM, Yang Y, Fleming TR, Muñoz-Fontela C, Wang R, Ellenberg SS, Qian G, Halloran ME, Nason M, Gruttola VD, Mulangu S, Huang Y, Donnelly CA, Henao Restrepo A. A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threats. Clinical Trials. 2022 Jul 22;19(6):647–54. doi: 10.1177/17407745221110880.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_90017f8815f6a8b3cdd3b4685a8c622b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f01cb2eb28718c8a760bdde570af4369 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c178cfd1cd088a33da21de778e8ab3b7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_302a7f678d9c93dcf7ed3e7806825674 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4b66cfc320474ebbeaae0f92d3941367 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0420-5068 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2772-6242 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2364-5253 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f9e3b58ee00e9c3d9b7dfe9702e972d0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1353a77ccb3a6db0932cf173a6f811cd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0ceb8640733e7aa642fe9ef56f462c7f http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2780-9382 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_83a733c2569ef287cd94d8f46bfcfaef
date	2022-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC9679315 https://pubmed.ncbi.nlm.nih.gov/35866633 https://doi.org/10.1177/17407745221110880
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32521 https://portal.issn.org/resource/ISSN/1740-7753 https://portal.issn.org/resource/ISSN/1740-7745
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threats
discusses	http://id.nlm.nih.gov/mesh/M0022453
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D014612 http://id.nlm.nih.gov/mesh/D029024 http://id.nlm.nih.gov/mesh/D008379Q000517 http://id.nlm.nih.gov/mesh/D000086382 http://id.nlm.nih.gov/mesh/D021821Q000517 http://id.nlm.nih.gov/mesh/D021821Q000453
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000086402 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000818
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6762 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10690 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8422

Total number of triples: 59.